Pediatric immunity refers to the complex and dynamic defense mechanisms that protect children from infections and maintain overall health. The immune system in children undergoes developmental changes from birth through adolescence, adapting to confront diverse pathogens while avoiding inappropriate responses to harmless substances. Neonatal immunity is initially influenced by maternal antibodies transferred during pregnancy and breastfeeding, providing passive protection. As infants grow, their immune system matures, and they develop active immunity through vaccination and exposure to pathogens. Pediatric immunity includes innate and adaptive components, involving various immune cells, antibodies, and cytokines. Early exposure to microbes helps shape the immune system's ability to distinguish between self and non-self, fostering tolerance. Vaccination plays a crucial role in pediatric immunity, preventing severe infectious diseases. Factors such as nutrition, genetics, and environmental exposures also impact immune development in children. Understanding pediatric immunity is essential for optimizing vaccination strategies, managing infections, and promoting overall well-being in pediatric populations. Ongoing research continues to enhance our knowledge of pediatric immune responses and inform strategies to improve child health.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe